|
US7029702B2
(en)
*
|
1998-07-07 |
2006-04-18 |
Ritter Natural Sciences Llc |
Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
|
|
SE523771C2
(sv)
*
|
1999-05-21 |
2004-05-18 |
Probi Ab |
Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
|
|
DE60127731T2
(de)
*
|
2000-05-25 |
2007-08-16 |
Société des Produits Nestlé S.A. |
Probiotica zur Verwendung als Futter für Haustiere
|
|
SE0003100D0
(sv)
*
|
2000-09-01 |
2000-09-01 |
Probi Ab |
New strains
|
|
SE0003576D0
(sv)
*
|
2000-10-04 |
2000-10-04 |
Probi Ab |
New strain
|
|
KR100419132B1
(ko)
*
|
2000-12-29 |
2004-02-18 |
조성근 |
위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:h7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이csk 01
|
|
SE0103695D0
(sv)
|
2001-11-07 |
2001-11-07 |
Thomas Boren |
A novel non-antibiotic strategy against OGIP infections based on a cereal product
|
|
PL212647B1
(pl)
|
2002-03-21 |
2012-11-30 |
Bifodan As |
Kompozycja farmaceutyczna, szczep Lactobacillus paracasei Lbp PB01 oraz szczep Lactobacillus paracasei Lbp PB01 w polaczeniu ze szczepem Lactobacillus acidophilus Lba EB01, produkt chlonny zawierajacy te kompozycje oraz produkt nabialowy, produkt nutraceutyczny i czynnosciowy produkt zywnosciowy zawierajace ten szczep albo te dwa szczepy, a takze zastosowanie tego szczepu albo tych dwóch szczepów
|
|
JP4308481B2
(ja)
*
|
2002-06-18 |
2009-08-05 |
独立行政法人農業・食品産業技術総合研究機構 |
抗アレルギー剤
|
|
SI1565547T2
(sl)
|
2002-06-28 |
2013-02-28 |
Biosearch S.A. |
Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
|
|
EP1384483A1
(en)
*
|
2002-07-23 |
2004-01-28 |
Nestec S.A. |
Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
|
|
JP2004189672A
(ja)
*
|
2002-12-11 |
2004-07-08 |
Gen Corp:Kk |
抗下痢症組成物
|
|
AU2004233658B2
(en)
*
|
2003-03-13 |
2009-10-29 |
Kirin Holdings Kabushiki Kaisha |
Antiallergic composition
|
|
EP1608737A1
(en)
*
|
2003-04-02 |
2005-12-28 |
Axcan Pharma S.A |
Lactobacillus fermentum strain and uses thereof
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
MY143693A
(en)
|
2004-03-24 |
2011-06-30 |
Nestec Sa |
Shelf stable product wih living micro-organisms
|
|
ITRM20040166A1
(it)
*
|
2004-03-31 |
2004-06-30 |
Alberto Cresci |
Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
|
|
US20080126195A1
(en)
*
|
2004-07-22 |
2008-05-29 |
Ritter Andrew J |
Methods and Compositions for Treating Lactose Intolerance
|
|
TW200637908A
(en)
*
|
2005-01-04 |
2006-11-01 |
Calpis Co Ltd |
Method for preparation of lactic acid bacterium having anti-allergic activity
|
|
AU2006233918B2
(en)
|
2005-04-13 |
2012-06-21 |
Nestec S.A. |
Infant formula with probiotics
|
|
US20060263311A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Scavone Timothy A |
Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
|
|
EP2261323A1
(en)
|
2005-05-31 |
2010-12-15 |
The Iams Company |
Feline probiotic lactobacilli
|
|
JP4938006B2
(ja)
|
2005-05-31 |
2012-05-23 |
ザ・アイムス・カンパニー |
ネコ科動物プロバイオティク・ビフィドバクテリア
|
|
KR101300086B1
(ko)
*
|
2005-10-06 |
2013-08-30 |
프로비 아베 |
자가면역질환의 치료를 위한 락토바실러스의 용도
|
|
AU2007216461B2
(en)
|
2006-02-15 |
2012-08-30 |
Société des Produits Nestlé S.A. |
Use of bifidobacterium longum for the prevention and treatment of inflammation
|
|
US9005682B2
(en)
|
2006-03-07 |
2015-04-14 |
Nestec S.A. |
Synbiotic mixture
|
|
DE502007004849D1
(de)
*
|
2007-02-02 |
2010-10-07 |
May Amadeus Alexander |
Produkt mit lebenden probiotischen Mikroorganismen
|
|
EP1974735A1
(en)
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Reduction of risk of diarrhoea
|
|
CN101273738B
(zh)
*
|
2007-03-28 |
2011-06-01 |
哈尔滨正方科技有限公司 |
在常温下保持高活菌数的调配型酸性乳饮料的制备方法
|
|
EP1974743A1
(en)
|
2007-03-28 |
2008-10-01 |
Nestec S.A. |
Probiotics to Improve Gut Microbiota
|
|
EP2173196B1
(en)
*
|
2007-07-06 |
2011-02-16 |
N.V. Nutricia |
Use of probiotics and fibers for diarrhoea
|
|
US20090110663A1
(en)
*
|
2007-10-24 |
2009-04-30 |
Halow George M |
Method for treatment of bowel disorders
|
|
EP2072052A1
(en)
|
2007-12-17 |
2009-06-24 |
Nestec S.A. |
Prevention of opportunistic infections in immune-compromised subjects
|
|
MY177280A
(en)
|
2008-01-24 |
2020-09-10 |
Nestle Sa |
Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
|
|
EP2265135B1
(en)
|
2008-03-14 |
2017-12-20 |
Nestec S.A. |
Synbiotic mixture
|
|
EP2127661A1
(en)
|
2008-05-27 |
2009-12-02 |
Nestec S.A. |
Probiotics to improve gut microbiotica
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
US20110189148A1
(en)
*
|
2008-06-25 |
2011-08-04 |
Ritter Pharmaceuticals, Inc. |
Lactose compositions with decreased lactose content
|
|
EP2147678A1
(en)
|
2008-07-21 |
2010-01-27 |
Nestec S.A. |
Probiotics to increase IgA secretion in infants born by caesarean section
|
|
EP2166083B1
(en)
*
|
2008-12-31 |
2010-12-22 |
Syngen biotech CO., LTD. |
Novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof
|
|
US20100196341A1
(en)
*
|
2009-02-05 |
2010-08-05 |
Syngen Biotech Co., Ltd. |
Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
|
|
CA2984935C
(en)
|
2009-02-24 |
2021-01-12 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
US8784798B2
(en)
*
|
2009-05-11 |
2014-07-22 |
Nestec S.A. |
Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
EP2509429A1
(en)
|
2009-12-08 |
2012-10-17 |
Nestec S.A. |
Infant formula with probiotics and milk fat globule membrane components
|
|
WO2011137249A1
(en)
|
2010-04-28 |
2011-11-03 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
EP2510932A1
(en)
*
|
2011-04-15 |
2012-10-17 |
Nestec S.A. |
Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
|
|
PT2734049T
(pt)
|
2011-06-20 |
2018-07-24 |
Heinz Co Brands H J Llc |
Composições e métodos probióticos
|
|
MX363899B
(es)
|
2012-06-18 |
2019-04-05 |
Heinz Co Brands H J Llc |
Trastornos relacionados con gluten.
|
|
BR112015028164B1
(pt)
|
2013-05-10 |
2022-02-08 |
H.J. Heinz Company Brands Llc |
Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
|
|
MX383245B
(es)
|
2014-12-05 |
2025-03-13 |
Synlogic Operating Co Inc |
Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
|
|
US9688967B2
(en)
|
2014-12-05 |
2017-06-27 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
CN107208044B
(zh)
|
2014-12-05 |
2021-08-13 |
同生运营公司 |
被工程化为治疗与高氨血症相关的疾病的细菌
|
|
US20160206666A1
(en)
|
2014-12-22 |
2016-07-21 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
|
|
KR20170121291A
(ko)
|
2015-03-02 |
2017-11-01 |
신로직 인코포레이티드 |
감소된 창자 염증 및/또는 강화된 창자 점막 장벽으로부터 이익을 얻는 질병을 치료하기 위해 공학처리된 박테리아
|
|
EP3882259B1
(en)
|
2015-05-13 |
2026-01-28 |
Synlogic Operating Company, Inc. |
Bacteria engineered to reduce hyperphenylalaninemia
|
|
EP3294757B1
(en)
|
2015-05-13 |
2023-12-27 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat a disease or disorder
|
|
AU2016274311A1
(en)
|
2015-06-10 |
2018-01-18 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2016210373A2
(en)
|
2015-06-24 |
2016-12-29 |
Synlogic, Inc. |
Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
|
|
WO2016210378A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Multi-layered control of gene expression in genetically engineered bacteria
|
|
WO2016210384A2
(en)
|
2015-06-25 |
2016-12-29 |
Synlogic, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
EP3328988A1
(en)
|
2015-07-31 |
2018-06-06 |
Synlogic, Inc. |
Bacteria engineered to treat disorders involving propionate catabolism
|
|
WO2017040719A1
(en)
|
2015-08-31 |
2017-03-09 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which oxalate is detrimental
|
|
WO2017074566A1
(en)
|
2015-10-30 |
2017-05-04 |
Dean Falb |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
US11685925B2
(en)
|
2015-10-30 |
2023-06-27 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
WO2017075485A1
(en)
|
2015-10-30 |
2017-05-04 |
Synlogic, Inc. |
Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
|
|
JP6993970B2
(ja)
|
2015-11-16 |
2022-02-15 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
高フェニルアラニン血症を低減させるように操作された細菌
|
|
EP3402497A1
(en)
|
2016-01-11 |
2018-11-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat metabolic diseases
|
|
WO2017123592A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to treat disorders associated with bile salts
|
|
WO2017123676A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
|
|
WO2017123675A1
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
|
WO2017123610A2
(en)
|
2016-01-11 |
2017-07-20 |
Synlogic, Inc. |
Bacteria engineered to detoxify deleterious molecules
|
|
WO2017136792A2
(en)
|
2016-02-04 |
2017-08-10 |
Synlogic, Inc. |
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
|
|
WO2017136795A1
(en)
|
2016-02-04 |
2017-08-10 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with tryptophan metabolism
|
|
WO2017139697A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat diseases associated with hyperammonemia
|
|
WO2017139708A1
(en)
|
2016-02-10 |
2017-08-17 |
Synlogic, Inc. |
Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
|
|
MX2018013760A
(es)
*
|
2016-05-11 |
2019-03-21 |
Chr Hansen As |
Bacterias de acido lactico para producto alimenticio tratado con calor para almacenamiento a temperatura ambiente.
|
|
MX2019008196A
(es)
|
2017-01-06 |
2019-12-16 |
Synlogic Operating Co Inc |
Microorganismos programados para producir moduladores inmunes y productos terapéuticos anti-cáncer en células tumorales.
|
|
US10941433B2
(en)
|
2017-06-15 |
2021-03-09 |
Iowa State University Research Foundation, Inc. |
Neurotransmitter transport in probiotics
|
|
EP3642221A1
(en)
|
2017-06-21 |
2020-04-29 |
Synlogic Operating Company, Inc. |
Bacteria for the treatment of disorders
|
|
AU2018301668A1
(en)
|
2017-07-12 |
2019-12-19 |
Synlogic Operating Company, Inc. |
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
|
|
US20210130806A1
(en)
|
2017-11-03 |
2021-05-06 |
Synlogic Operating Company, Inc. |
Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
|
|
WO2020063531A1
(zh)
|
2018-09-30 |
2020-04-02 |
内蒙古伊利实业集团股份有限公司 |
副干酪乳杆菌et-22及其用途
|
|
CN110960559B
(zh)
*
|
2018-09-30 |
2021-02-26 |
内蒙古伊利实业集团股份有限公司 |
用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
|
|
KR20220003030A
(ko)
|
2019-04-29 |
2022-01-07 |
신로직 오퍼레이팅 컴퍼니, 인코포레이티드 |
살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
|
|
CN114144078B
(zh)
|
2019-07-23 |
2024-06-11 |
菲仕兰坎皮纳荷兰公司 |
包含乳脂肪和免疫球蛋白的营养组合物
|
|
AU2020354581A1
(en)
|
2019-09-24 |
2022-03-03 |
Prolacta Bioscience, Inc. |
Compositions and methods for treatment of inflammatory and immune diseases
|
|
MX2022007925A
(es)
|
2019-12-24 |
2022-09-29 |
Univ Iowa State Res Found Inc |
Control de histamina para promover la salud y controlar la enterocolitis usando composiciones probioticas y/o enzimas, que degrada histamina.
|
|
CN113355252A
(zh)
*
|
2020-03-06 |
2021-09-07 |
南京卫岗乳业有限公司 |
一种副干酪乳杆菌及其应用
|
|
WO2021188819A1
(en)
|
2020-03-20 |
2021-09-23 |
Synlogic Operating Company, Inc. |
Microorganisms engineered to reduce hyperphenylalaninemia
|
|
CA3188645A1
(en)
|
2020-08-14 |
2022-02-17 |
Prolacta Bioscience, Inc. |
Human milk oligosaccharide compositions for use with bacteriotherapies
|
|
AU2021393455A1
(en)
|
2020-12-02 |
2023-06-29 |
Synlogic Operating Company, Inc. |
Engineered microorganisms
|
|
WO2022146718A1
(en)
|
2020-12-31 |
2022-07-07 |
Synlogic Operating Company, Inc. |
Microorganisms engineered to reduce hyperphenylalaninemia
|
|
MX2023008227A
(es)
|
2021-01-12 |
2023-07-20 |
Prolacta Bioscience Inc |
Regimenes de tratamiento simbiotico.
|
|
CN112625983B
(zh)
*
|
2021-03-05 |
2021-05-28 |
山东中科嘉亿生物工程有限公司 |
一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
|
|
CN112877260B
(zh)
*
|
2021-03-30 |
2022-08-09 |
江南大学 |
一株缓解泻剂结肠的副干酪乳杆菌及其应用
|
|
EP4323385A1
(en)
|
2021-04-13 |
2024-02-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to secrete active proteins
|
|
CN115671144A
(zh)
*
|
2021-07-26 |
2023-02-03 |
锦乔生物科技有限公司 |
使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
|
|
WO2023044479A1
(en)
|
2021-09-17 |
2023-03-23 |
Synlogic Operating Company, Inc. |
Methods for reducing hyperphenylalaninemia
|
|
WO2023245171A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
|
WO2023245168A1
(en)
|
2022-06-17 |
2023-12-21 |
Synlogic Operating Company, Inc. |
Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
|
|
US20230414679A1
(en)
|
2022-06-22 |
2023-12-28 |
Iowa State University Research Foundation, Inc. |
Control of histamine to promote health and control enterocolitis using probiotic compositions
|
|
US20260199405A1
(en)
|
2022-06-23 |
2026-07-16 |
Synlogic Operating Company, Inc. |
Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
|
|
WO2024081768A1
(en)
|
2022-10-12 |
2024-04-18 |
Synlogic Operating Company, Inc. |
Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
|
|
JP2025534764A
(ja)
|
2022-10-17 |
2025-10-17 |
シンロジック オペレーティング カンパニー インコーポレイテッド |
高フェニルアラニン血症を軽減するためのフェニルアラニンアンモニアリアーゼ、フェニルアラニントランスポーターおよびl-アミノ酸デアミナーゼを発現する組み換え細菌
|
|
WO2024129974A1
(en)
|
2022-12-14 |
2024-06-20 |
Synlogic Operating Company, Inc. |
Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
|
|
WO2024130119A2
(en)
|
2022-12-16 |
2024-06-20 |
Prolacta Bioscience, Inc. |
Synbiotic compositions for short chain fatty acid production
|
|
EP4647439A1
(en)
|
2024-05-09 |
2025-11-12 |
Alma Mater Studiorum - Università di Bologna |
Non-pathogenic bacteria for delivery of ptd-fusion proteins
|